Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA™®) over a 6-month period.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02322229
Study type Interventional
Source Alcon Research
Contact
Status Completed
Phase Phase 4
Start date May 26, 2015
Completion date May 9, 2016

See also
  Status Clinical Trial Phase
Completed NCT06038968 - Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy Early Phase 1
Terminated NCT04300881 - Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists) Phase 2
Active, not recruiting NCT01966328 - A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment Phase 1
Completed NCT03647267 - Effects of Pneumatic Vitreolysis on Vitreomacular Traction Phase 3
Recruiting NCT02290795 - Vitreopapillary Interface and Optic Disc Morphology N/A
Completed NCT05287269 - Ocular Coherence Tomography During Cataract Assessment
Completed NCT05517473 - Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains
Completed NCT01162356 - Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study N/A
Recruiting NCT05588037 - Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery N/A
Completed NCT00435539 - A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt) Phase 2
Recruiting NCT00892619 - Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel N/A
Completed NCT02035748 - Assessment of Patients Treated With JETREA® for Vitreomacular Traction Phase 4
Recruiting NCT05860985 - Zeiss RESIGHT Disposable Lenses Evaluation Study N/A